Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Latest News about Approval
< Previous
1
2
Next >
Novartis drug Jakavi® first medication to receive European Commission approval to treat patients with myelofibrosis
August 28, 2012
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Shareholders approve all proposed resolutions of Novartis Board of Directors
February 27, 2012
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
European Commission approves new label for Novartis drug Glivec® extending adjuvant therapy to three years for certain GIST patients
February 27, 2012
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
BASF applies for European approval for Fortuna, a disease-resistant table potato
November 01, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
New active ingredient Xemium® receives registration in Europe in time for the growing season 2011/12
October 25, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
BASF starts mining solutions venture in China
October 25, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
BASF SE and INEOS AG have received approvals from all relevant antitrust authorities
October 04, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
Novartis receives approval in Japan for two innovative therapies, Gilenya® in MS and Ilaris® in CAPS
September 28, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis receives EU approval for Votubia®, the first medication to treat children and adults with SEGA associated with TSC
September 09, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis receives EU approval for Votubia®, the first medication to treat children and adults with SEGA associated with TSC
September 09, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Pilot project with compostable bags for biodegradable waste successfully completed in Bad Dürkheim, Germany
September 09, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
Pilot project with compostable bags for biodegradable waste successfully completed in Bad Dürkheim, Germany
September 09, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors
September 06, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors
September 06, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis
September 01, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty
August 18, 2011
about
ABT
category
Approval
,
Healthcare
,
Biotechnology and Drugs
from
1888PressRelease - Full Feed
Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty
August 18, 2011
about
ABT
category
Approval
,
Healthcare
,
Biotechnology and Drugs
from
1888PressRelease - Full Feed
FDA approves Zelboraf (vemurafenib) and companion diagnostic for BRAF mutation-positive metastatic melanoma, a deadly form of skin cancer
August 18, 2011
about
RHHBY
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Abbott Receives U.S. FDA Approval for RX Herculink Elite Renal Stent System for Treatment of Renal Artery Disease
August 12, 2011
about
ABT
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Roche's RoACTEMRA approved in Europe for children living with a rare and severe form of arthritis
August 04, 2011
about
RHHBY
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
RWE Dea announces Breagh Field Development Plan Approval
July 26, 2011
about
RWEOY
,
SERVICES
category
Approval
,
Services
,
Energy Services
from
1888PressRelease - Full Feed
Novartis drug Afinitor® recommended by CHMP for EU approval to treat patients with advanced pancreatic neuroendocrine tumors
July 23, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease
July 04, 2011
about
NVS
,
TM
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis receives approval in Japan for Onbrez® Inhalation Capsules, a novel once-daily bronchodilator therapy for patients with COPD
July 04, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis drug Votubia® recommended by CHMP for approval in the EU for children and adults with SEGA associated with tuberous sclerosis
July 01, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Abbott Receives FDA Approval For CREON (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis
June 17, 2011
about
ABT
category
Approval
,
Healthcare
,
Biotechnology and Drugs
from
1888PressRelease - Full Feed
Novartis gains European Commission approval for Lucentis® to treat vision loss due to macular edema secondary to RVO
June 06, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
EU Commission approves formation of joint venture Styrolution
June 02, 2011
about
BASFY
category
Approval
,
Chemical Products
,
Production
from
1888PressRelease - Full Feed
Novartis drug Votubia® approved as first medication in Switzerland for SEGA, a benign brain tumor associated with tuberous sclerosis
May 11, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
Novartis gains FDA approval for Afinitor® as first new treatment in nearly three decades for patients with advanced pancreatic NET
May 07, 2011
about
NVS
category
Approval
,
Major Drugs
,
Healthcare
from
1888PressRelease - Full Feed
< Previous
1
2
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here